159 related articles for article (PubMed ID: 27454620)
21. 2-Oxo-1,2,3,4-tetrahydropyrimidines Ethyl Esters as Potent β- Glucuronidase Inhibitors: One-pot Synthesis, In vitro and In silico Studies.
Iqbal S; Shaikh NN; Khan KM; Naz S; Ul-Haq Z; Perveen S; Choudhary MI
Med Chem; 2018; 14(8):818-830. PubMed ID: 29793412
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of Chromen-4-One-Oxadiazole Substituted Analogs as Potent
Taha M; Rahim F; Ali M; Khan MN; Alqahtani MA; Bamarouf YA; Gollapalli M; Farooq RK; Shah SAA; Ahmed QU; Zakaria ZA
Molecules; 2019 Apr; 24(8):. PubMed ID: 31003424
[TBL] [Abstract][Full Text] [Related]
23. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
Maddela S; Makula A; Jayarambabu N
Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
[TBL] [Abstract][Full Text] [Related]
24. 2,5-Disubstituted thiadiazoles as potent β-glucuronidase inhibitors; Synthesis, in vitro and in silico studies.
Taha M; Barak Almandil N; Rashid U; Ali M; Ibrahim M; Gollapalli M; Mosaddik A; Mohammed Khan K
Bioorg Chem; 2019 Oct; 91():103126. PubMed ID: 31349116
[TBL] [Abstract][Full Text] [Related]
25. 2,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors.
Li YS; He M; Zhou TS; Wang Q; He L; Wang SJ; Hu B; Wei B; Wang H; Cui ZN
Eur J Med Chem; 2021 Apr; 216():113322. PubMed ID: 33652353
[TBL] [Abstract][Full Text] [Related]
26. Thiazolidin-2-cyanamides derivatives as novel potent
Zhou TS; Wei B; He M; Li YS; Wang YK; Wang SJ; Chen JW; Zhang HW; Cui ZN; Wang H
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1736-1742. PubMed ID: 32928007
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor activity of novel pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-one derivatives.
El-Nassan HB
Eur J Med Chem; 2011 Jun; 46(6):2031-6. PubMed ID: 21429629
[TBL] [Abstract][Full Text] [Related]
28. One-pot synthesis of thioxo-tetrahydropyrimidine derivatives as potent β-glucuronidase inhibitor, biological evaluation, molecular docking and molecular dynamics studies.
Iraji A; Nouri A; Edraki N; Pirhadi S; Khoshneviszadeh M; Khoshneviszadeh M
Bioorg Med Chem; 2020 Apr; 28(7):115359. PubMed ID: 32098709
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives.
Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W
Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, β-glucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids.
Abid O; Imran S; Taha M; Ismail NH; Jamil W; Kashif SM; Khan KM; Yusoff J
Mol Divers; 2021 May; 25(2):995-1009. PubMed ID: 32301032
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors.
Taha M; Baharudin MS; Ismail NH; Selvaraj M; Salar U; Alkadi KA; Khan KM
Bioorg Chem; 2017 Apr; 71():86-96. PubMed ID: 28160943
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, in vitro β-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles.
Salar U; Khan KM; Syed S; Taha M; Ali F; Ismail NH; Perveen S; Wadood A; Ghufran M
Bioorg Chem; 2017 Feb; 70():199-209. PubMed ID: 28069264
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a series of 5-phenyl-2-furan derivatives containing 1,3-thiazole moiety as potent Escherichia coli β-glucuronidase inhibitors.
Zhou TS; He LL; He J; Yang ZK; Zhou ZY; Du AQ; Yu JB; Li YS; Wang SJ; Wei B; Cui ZN; Wang H
Bioorg Chem; 2021 Nov; 116():105306. PubMed ID: 34521047
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
[TBL] [Abstract][Full Text] [Related]
35. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
37. EGFR, HER2 target based molecular docking analysis, in vitro screening of 2, 4, 5-trisubstituted imidazole derivatives as potential anti-oxidant and cytotoxic agents.
Guda R; Kumar G; Korra R; Balaji S; Dayakar G; Palabindela R; Myadaraveni P; Yellu NR; Kasula M
J Photochem Photobiol B; 2017 Nov; 176():69-80. PubMed ID: 28964888
[TBL] [Abstract][Full Text] [Related]
38. Pyrimidinedione-mediated selective histone deacetylase 6 inhibitors with antitumor activity in colorectal cancer HCT116 cells.
Liu YM; Lee HY; Lai MJ; Pan SL; Huang HL; Kuo FC; Chen MC; Liou JP
Org Biomol Chem; 2015 Oct; 13(40):10226-35. PubMed ID: 26309122
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, anticancer and antioxidant activities of some novel N-(benzo[d]oxazol-2-yl)-2-(7- or 5-substituted-2-oxoindolin-3-ylidene) hydrazinecarboxamide derivatives.
Gudipati R; Anreddy RN; Manda S
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):813-8. PubMed ID: 21476831
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives.
Anouar EH; Moustapha ME; Taha M; Geesi MH; Farag ZR; Rahim F; Almandil NB; Farooq RK; Nawaz M; Mosaddik A
Molecules; 2019 Mar; 24(5):. PubMed ID: 30857263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
